Aravive to Present Updated Clinical Data from Batiraxcept Trials in Renal and Pancreatic Cancer at…
HOUSTON, July 28, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage…
Read More...
Read More...
Browsing Tag
Pancreatic
Global fecal pancreatic elastase testing market was estimated at a market value of US$ 2.4 million…
Wilmington, Delaware, July 18, 2023 (GLOBE NEWSWIRE) -- According to a deep-dive market assessment by RationalStat,…
Read More...
Read More...
Pancreatic cancer vaccine plus immunotherapy and antibody spark immune system response in pancreatic…
Giving patients with operable pancreatic cancers a three-pronged combination immunotherapy treatment consisting of the…
Read More...
Read More...
FAK Inhibitor Boosts Anti-PD1 Immunotherapy in Pancreatic Cancer
At the American Society…
Read More...
Read More...
Purple Biotech Reports Positive Results of CM24 Dose Escalation in Advanced Pancreatic Cancer…
Purple’s innovative immuno-oncology, chemotherapy-free regimen reports encouraging Overall Survival data in 3rd line…
Read More...
Read More...
Vaccine Slows Return of Pancreatic Cancer in Early Trial
Cara Murez
THURSDAY, May 11, 2023 (HealthDay News) – A gene-targeted personalized…
Read More...
Read More...
Even at Stage IV, Immunotherapy Helps in Pancreatic Cancer
CHICAGO -- Real-world data demonstrate that…
Read More...
Read More...
Exposure to chemical agents heightens pancreatic cancer risk
Working with chemical agents increases a person’s risk of developing pancreatic cancer with every year of exposure,…
Read More...
Read More...